Author

Yantong Li

China Pharmaceutical UniversityORCID 0000-0002-9703-3882Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Chenghao FuiD· 1 shared Fang ZhouiD· 1 shared Feiyi WangiD· 1 shared Guangji WangiD· 1 shared Haobin LiiD· 1 shared Jia WeiiD· 1 shared Jiali LiuiD· 1 shared Jiawen CuiiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chenghao FuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting GFPT2 to reinvigorate immunotherapy in EGFR-mutated NSCLC

Luyao Ao, Wenjing Jia, Qixing Gong, Jiawen Cui, Jun Wang, Ying Yu, Chenghao Fu, Haobin Li, Jia Wei, Ruiqi L. Wang, Feiyi Wang, Xin Chun Shang, Yantong Li, Shencun Fang, Guangji Wang, , Jiali Liu

This study identifies GFPT2 as a metabolic checkpoint in EGFR-mutated NSCLC that promotes immune evasion, and shows that targeting GFPT2 enhances PD-1 blockade therapy.

bioRxiv · Mar 1, 2024 · PreprintCancer Biology